First Capital S.p.A. is an independent financial holding and investment company specializing in private equity, private investment in public equity (PIPE), and pre-IPO financing solutions for small and medium-sized enterprises (SMEs). Founded in 2008 and headquartered in Milan, Italy, the company operates primarily across the Italian market, targeting high-growth businesses across diverse industries such as industrial manufacturing, specialized services, information technology, healthcare, and the circular economy. The firm provides tailored equity, debt, and managerial solutions structured into systematic offerings: private equity financing, comprising growth capital, expansion equity, and minority or controlling investments in private enterprises; private investment in public equity (PIPE) transactions, involving significant equity stakes in listed small and mid-cap companies on public markets such as Euronext Growth Milan; pre-IPO acceleration and bridge financing, assisting private firms with capital structuring and regulatory readiness ahead of public listings; hybrid and structured financial instruments, consisting of ordinary and preference shares, convertible bond issues, subordinated loans, and equity warrants; active governance and advisory services, including board-level strategic management, M&A guidance, capital restructuring, and international growth support; and dedicated investment vehicle management, structured through First SICAF S.p.A., an alternative investment fund platform reserved for professional investors, and the First4Progress series of search investment vehicles (SIVs). In recent company developments, First Capital has expanded its investment vehicle infrastructure through the introduction and deployment of First4Progress 2 to co-invest alongside First SICAF in high-potential growth enterprises. The company has also strategically diversified its portfolio into sustainable and circular economy sectors, notably acquiring a significant equity stake in Recupero Etico Sostenibile S.p.A. (RES), investing in specialized healthcare retail provider Più Medical, and executing portfolio optimization transactions such as the exit of its stake in Orsero S.p.A. via an accelerated bookbuilding procedure.